Rep. Cathy McMorris Rodgers, chair of the House Energy and Commerce Committee, has reached out to the FDA and Federal Trade Commission to regulate telehealth ads. Reporting from the Journal found that during a four-week period, more than 1,800 social media ads from telehealth companies promoted prescription drugs without warning of side effects.
Rep. Andy Harris, MD, is particularly concerned with telehealth companies pushing Adderall for patients without an attention-deficit/hyperactivity disorder diagnosis and ketamine as treatment for anxiety and depression.
“As an anesthesiologist, I feel this is beyond concerning,” Dr. Harris said. “I intend to continue working with the FDA and my physician colleagues in Congress to stop these bad actors, while expanding telehealth access where appropriate and helpful.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.